Open AccessCase Report: - A Case of Pulmonary Aspergilloma
Author(s) -
Yasser Shaban Mubarak
Publication year - 2020
Publication title -
international journal of innovative science and research technology
Language(s) - English
Resource type - Journals
ISSN - 2456-2165
DOI - 10.38124/ijisrt20sep348
Subject(s) - aspergilloma , medicine , mycetoma , asymptomatic , allergic bronchopulmonary aspergillosis , embolization , aspergillosis , chest pain , surgery , antifungal , productive cough , lung , radiology , dermatology , immunology , immunoglobulin e , antibody
Virchowdescribed the pathology of human aspergillosisin 1856. Hinson and colleagues classified pulmonary aspergillosis into allergic, invasive, and saprophytic infections. Saprophytic type colonized in pre-existing lung cavity and produceda fungus ball, or aspergilloma. (4) Pulmonary aspergilloma (fungus ball or Mycetoma) is rare pulmonary infectious disease. Its clinical manifestation includes; chronic cough, fever, dyspnea, chest pain, hemoptysis and others, but it may be asymptomatic. (1)It is a potentially life-threatening disease that is difficult to treat without surgical intervention, which is the treatment of choicein selected cases. It does not respond to antifungal agents alone.(5)In cases of high surgical morbidity and mortality, alternative the rapiesare needed.(3)Bronchial artery embolization can be used to treat massive hemoptysis but is rarely completely effective due to the existence of massive collateral blood vessels.(5)